Cargando…

Theabrownin Inhibits Cell Cycle Progression and Tumor Growth of Lung Carcinoma through c-myc-Related Mechanism

Green tea, the fresh leaves of Camellia sinensis, is not only a health-promoting beverage but also a traditional Chinese medicine used for prevention or treatment of cancer, such as lung cancer. Theabrownin (TB) is the main fraction responsible for the medicinal effects of green tea, but whether it...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Li, Wu, Feifei, Jin, Wangdong, Yan, Bo, Chen, Xin, He, Yingfei, Yang, Weiji, Du, Wenlin, Zhang, Qiang, Guo, Yonghua, Yuan, Qiang, Dong, Xiaoqiao, Yu, Wenhua, Zhang, Jin, Xiao, Luwei, Tong, Peijian, Shan, Letian, Efferth, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5326752/
https://www.ncbi.nlm.nih.gov/pubmed/28289384
http://dx.doi.org/10.3389/fphar.2017.00075
_version_ 1782510590730698752
author Zhou, Li
Wu, Feifei
Jin, Wangdong
Yan, Bo
Chen, Xin
He, Yingfei
Yang, Weiji
Du, Wenlin
Zhang, Qiang
Guo, Yonghua
Yuan, Qiang
Dong, Xiaoqiao
Yu, Wenhua
Zhang, Jin
Xiao, Luwei
Tong, Peijian
Shan, Letian
Efferth, Thomas
author_facet Zhou, Li
Wu, Feifei
Jin, Wangdong
Yan, Bo
Chen, Xin
He, Yingfei
Yang, Weiji
Du, Wenlin
Zhang, Qiang
Guo, Yonghua
Yuan, Qiang
Dong, Xiaoqiao
Yu, Wenhua
Zhang, Jin
Xiao, Luwei
Tong, Peijian
Shan, Letian
Efferth, Thomas
author_sort Zhou, Li
collection PubMed
description Green tea, the fresh leaves of Camellia sinensis, is not only a health-promoting beverage but also a traditional Chinese medicine used for prevention or treatment of cancer, such as lung cancer. Theabrownin (TB) is the main fraction responsible for the medicinal effects of green tea, but whether it possesses anti-cancer effect is unknown yet. This study aimed to determine the in vitro and in vivo anti-lung cancer effect of TB and explore the underlying molecular mechanism, by using A549 cell line and Lewis lung carcinoma-bearing mice. In cellular experiment, MTT assay was performed to evaluate the inhibitory effect and IC50 values of TB, and flow cytometry was conducted to analyze the cell cycle progression affected by TB. In animal experiment, mice body mass, tumor incidence, tumor size and tumor weight were measured, and histopathological analysis on tumor was performed with Transferase dUTP nick-end labeling staining. Real time PCR and western blot assays were adopted to detect the expression of C-MYC associated genes and proteins for mechanism clarification. TB was found to inhibit A549 cell viability in a dose- and time-dependent manner and block A549 cell cycle at G0/G1 phase. Down-regulation of c-myc, cyclin A, cyclin D, cdk2, cdk4, proliferation of cell nuclear antigen and up-regulation of p21, p27, and phosphate and tension homolog in both gene and protein levels were observed with TB treatment. A c-myc-related mechanism was thereby proposed, since c-myc could transcriptionally regulate all other genes in its downstream region for G1/S transitions of cell cycle and proliferation of cancer cells. This is the first report regarding the anti-NSCLC effect and the underlying mechanism of TB on cell cycle progression and proliferation of A549 cells. The in vivo data verified the in vitro result that TB could significantly inhibit the lung cancer growth in mice and induce apoptosis on tumors in a dose-dependent manner. It provides a promising candidate of natural products for lung cancer therapy and new development of anti-cancer agent.
format Online
Article
Text
id pubmed-5326752
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-53267522017-03-13 Theabrownin Inhibits Cell Cycle Progression and Tumor Growth of Lung Carcinoma through c-myc-Related Mechanism Zhou, Li Wu, Feifei Jin, Wangdong Yan, Bo Chen, Xin He, Yingfei Yang, Weiji Du, Wenlin Zhang, Qiang Guo, Yonghua Yuan, Qiang Dong, Xiaoqiao Yu, Wenhua Zhang, Jin Xiao, Luwei Tong, Peijian Shan, Letian Efferth, Thomas Front Pharmacol Pharmacology Green tea, the fresh leaves of Camellia sinensis, is not only a health-promoting beverage but also a traditional Chinese medicine used for prevention or treatment of cancer, such as lung cancer. Theabrownin (TB) is the main fraction responsible for the medicinal effects of green tea, but whether it possesses anti-cancer effect is unknown yet. This study aimed to determine the in vitro and in vivo anti-lung cancer effect of TB and explore the underlying molecular mechanism, by using A549 cell line and Lewis lung carcinoma-bearing mice. In cellular experiment, MTT assay was performed to evaluate the inhibitory effect and IC50 values of TB, and flow cytometry was conducted to analyze the cell cycle progression affected by TB. In animal experiment, mice body mass, tumor incidence, tumor size and tumor weight were measured, and histopathological analysis on tumor was performed with Transferase dUTP nick-end labeling staining. Real time PCR and western blot assays were adopted to detect the expression of C-MYC associated genes and proteins for mechanism clarification. TB was found to inhibit A549 cell viability in a dose- and time-dependent manner and block A549 cell cycle at G0/G1 phase. Down-regulation of c-myc, cyclin A, cyclin D, cdk2, cdk4, proliferation of cell nuclear antigen and up-regulation of p21, p27, and phosphate and tension homolog in both gene and protein levels were observed with TB treatment. A c-myc-related mechanism was thereby proposed, since c-myc could transcriptionally regulate all other genes in its downstream region for G1/S transitions of cell cycle and proliferation of cancer cells. This is the first report regarding the anti-NSCLC effect and the underlying mechanism of TB on cell cycle progression and proliferation of A549 cells. The in vivo data verified the in vitro result that TB could significantly inhibit the lung cancer growth in mice and induce apoptosis on tumors in a dose-dependent manner. It provides a promising candidate of natural products for lung cancer therapy and new development of anti-cancer agent. Frontiers Media S.A. 2017-02-27 /pmc/articles/PMC5326752/ /pubmed/28289384 http://dx.doi.org/10.3389/fphar.2017.00075 Text en Copyright © 2017 Zhou, Wu, Jin, Yan, Chen, He, Yang, Du, Zhang, Guo, Yuan, Dong, Yu, Zhang, Xiao, Tong, Shan and Efferth. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Zhou, Li
Wu, Feifei
Jin, Wangdong
Yan, Bo
Chen, Xin
He, Yingfei
Yang, Weiji
Du, Wenlin
Zhang, Qiang
Guo, Yonghua
Yuan, Qiang
Dong, Xiaoqiao
Yu, Wenhua
Zhang, Jin
Xiao, Luwei
Tong, Peijian
Shan, Letian
Efferth, Thomas
Theabrownin Inhibits Cell Cycle Progression and Tumor Growth of Lung Carcinoma through c-myc-Related Mechanism
title Theabrownin Inhibits Cell Cycle Progression and Tumor Growth of Lung Carcinoma through c-myc-Related Mechanism
title_full Theabrownin Inhibits Cell Cycle Progression and Tumor Growth of Lung Carcinoma through c-myc-Related Mechanism
title_fullStr Theabrownin Inhibits Cell Cycle Progression and Tumor Growth of Lung Carcinoma through c-myc-Related Mechanism
title_full_unstemmed Theabrownin Inhibits Cell Cycle Progression and Tumor Growth of Lung Carcinoma through c-myc-Related Mechanism
title_short Theabrownin Inhibits Cell Cycle Progression and Tumor Growth of Lung Carcinoma through c-myc-Related Mechanism
title_sort theabrownin inhibits cell cycle progression and tumor growth of lung carcinoma through c-myc-related mechanism
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5326752/
https://www.ncbi.nlm.nih.gov/pubmed/28289384
http://dx.doi.org/10.3389/fphar.2017.00075
work_keys_str_mv AT zhouli theabrownininhibitscellcycleprogressionandtumorgrowthoflungcarcinomathroughcmycrelatedmechanism
AT wufeifei theabrownininhibitscellcycleprogressionandtumorgrowthoflungcarcinomathroughcmycrelatedmechanism
AT jinwangdong theabrownininhibitscellcycleprogressionandtumorgrowthoflungcarcinomathroughcmycrelatedmechanism
AT yanbo theabrownininhibitscellcycleprogressionandtumorgrowthoflungcarcinomathroughcmycrelatedmechanism
AT chenxin theabrownininhibitscellcycleprogressionandtumorgrowthoflungcarcinomathroughcmycrelatedmechanism
AT heyingfei theabrownininhibitscellcycleprogressionandtumorgrowthoflungcarcinomathroughcmycrelatedmechanism
AT yangweiji theabrownininhibitscellcycleprogressionandtumorgrowthoflungcarcinomathroughcmycrelatedmechanism
AT duwenlin theabrownininhibitscellcycleprogressionandtumorgrowthoflungcarcinomathroughcmycrelatedmechanism
AT zhangqiang theabrownininhibitscellcycleprogressionandtumorgrowthoflungcarcinomathroughcmycrelatedmechanism
AT guoyonghua theabrownininhibitscellcycleprogressionandtumorgrowthoflungcarcinomathroughcmycrelatedmechanism
AT yuanqiang theabrownininhibitscellcycleprogressionandtumorgrowthoflungcarcinomathroughcmycrelatedmechanism
AT dongxiaoqiao theabrownininhibitscellcycleprogressionandtumorgrowthoflungcarcinomathroughcmycrelatedmechanism
AT yuwenhua theabrownininhibitscellcycleprogressionandtumorgrowthoflungcarcinomathroughcmycrelatedmechanism
AT zhangjin theabrownininhibitscellcycleprogressionandtumorgrowthoflungcarcinomathroughcmycrelatedmechanism
AT xiaoluwei theabrownininhibitscellcycleprogressionandtumorgrowthoflungcarcinomathroughcmycrelatedmechanism
AT tongpeijian theabrownininhibitscellcycleprogressionandtumorgrowthoflungcarcinomathroughcmycrelatedmechanism
AT shanletian theabrownininhibitscellcycleprogressionandtumorgrowthoflungcarcinomathroughcmycrelatedmechanism
AT efferththomas theabrownininhibitscellcycleprogressionandtumorgrowthoflungcarcinomathroughcmycrelatedmechanism